Matulionė, J. “FIRST-LINE NIVOLUMAB PLUS IPILIMUMAB COMBINED WITH TWO CYCLES OF CHEMOTHERAPY IN PATIENTS WITH NON-SMALL-CELL LUNG CANCER”. Pulmonology and Allergology, Vol. 6, no. 1, June 2022, pp. 97-104, doi:10.37499/PIA.973.